Not all statins are alike: induced rhabdomyolysis on changing from one statin to antoher one. Letter to the editor

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F05%3A00001106" target="_blank" >RIV/00023001:_____/05:00001106 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Not all statins are alike: induced rhabdomyolysis on changing from one statin to antoher one. Letter to the editor
Original language description
A 59-year-old woman underwent orthotopic heart transplantation 4 years earlier. At the time of transplantation, she was receiving pravastatin at a dose of 20 mg per day; she tolerated subsequent combination with immunosuppression (cyclosporine A, prednisone, mycophenolate mofetil) very well throughout the 4 years. After switching from pravastatin to simvastatin, she developed severe muscular weakness and laboratory evidence of muscle break down. Biochemical markers of rhabdomyolysis did not subside until after repeat hemodialysis and normalized after 2 months in conjunction with improved renal function. Clinical improvement was not apparent until after 5 months.
Czech name
Všechny statiny si nejsou podobné: indukovaná rhabdomyolýza při přechodu z jednoho statinu na jiný. Dopis editorovi
Czech description
ortotopická transplantace srdce, pravastatin, imunosuprese, cyklosporin

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—

Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)